File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1080/09540261.2019.1613965
- Scopus: eid_2-s2.0-85073965499
- PMID: 31225767
- WOS: WOS:000475121600001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia
Title | A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia |
---|---|
Authors | |
Keywords | Schizophrenia antipsychotics treatment guideline recommendation |
Issue Date | 2019 |
Publisher | Taylor & Francis. The Journal's web site is located at http://www.tandfonline.com/toc/iirp20/current |
Citation | International Review of Psychiatry, 2019, v. 31 n. 5-6, p. 441-459 How to Cite? |
Abstract | Clinical guidelines provide evidence-based recommendations to regulate pharmacological treatment of psychotic disorders. However, the quality of evidence, country of origin, and publication dates of such guidelines vary, which leads to discrepancies between recommendations. This systematic review aimed to examine consensus and disparities between clinical recommendations on the choice, dose, and duration of antipsychotic treatment for first- and multi-episode schizophrenia patients. A literature search through The Cochrane Library, Embase, Medline, PsycINFO, PubMed, Scopus, Web of Sciences, and relevant bibliographies revealed 24 guidelines that met the inclusion criteria. The guidelines indicated mostly consistent recommendations regarding the optimal dose range of antipsychotics, while guidance with regards to the choice and duration of treatment remains somewhat controversial. Current trends in guidelines emphasize that there is simply no ‘one-size-fits-all’ method to manage schizophrenia patients. Further research is needed not only to address discrepancies between guidelines, but also to justify the gap between theory and practice. |
Persistent Identifier | http://hdl.handle.net/10722/282954 |
ISSN | 2021 Impact Factor: 3.287 2020 SCImago Journal Rankings: 1.184 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hui, CLM | - |
dc.contributor.author | Lam, BST | - |
dc.contributor.author | Lee, EHM | - |
dc.contributor.author | Chan, SKW | - |
dc.contributor.author | Chang, WC | - |
dc.contributor.author | Suen, YN | - |
dc.contributor.author | Chen, EYH | - |
dc.date.accessioned | 2020-06-05T06:23:28Z | - |
dc.date.available | 2020-06-05T06:23:28Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | International Review of Psychiatry, 2019, v. 31 n. 5-6, p. 441-459 | - |
dc.identifier.issn | 0954-0261 | - |
dc.identifier.uri | http://hdl.handle.net/10722/282954 | - |
dc.description.abstract | Clinical guidelines provide evidence-based recommendations to regulate pharmacological treatment of psychotic disorders. However, the quality of evidence, country of origin, and publication dates of such guidelines vary, which leads to discrepancies between recommendations. This systematic review aimed to examine consensus and disparities between clinical recommendations on the choice, dose, and duration of antipsychotic treatment for first- and multi-episode schizophrenia patients. A literature search through The Cochrane Library, Embase, Medline, PsycINFO, PubMed, Scopus, Web of Sciences, and relevant bibliographies revealed 24 guidelines that met the inclusion criteria. The guidelines indicated mostly consistent recommendations regarding the optimal dose range of antipsychotics, while guidance with regards to the choice and duration of treatment remains somewhat controversial. Current trends in guidelines emphasize that there is simply no ‘one-size-fits-all’ method to manage schizophrenia patients. Further research is needed not only to address discrepancies between guidelines, but also to justify the gap between theory and practice. | - |
dc.language | eng | - |
dc.publisher | Taylor & Francis. The Journal's web site is located at http://www.tandfonline.com/toc/iirp20/current | - |
dc.relation.ispartof | International Review of Psychiatry | - |
dc.rights | AOM/Preprint Before Accepted: his article has been accepted for publication in [JOURNAL TITLE], published by Taylor & Francis. AOM/Preprint After Accepted: This is an [original manuscript / preprint] of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/[Article DOI]. Accepted Manuscript (AM) i.e. Postprint This is an Accepted Manuscript of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/[Article DOI]. | - |
dc.subject | Schizophrenia | - |
dc.subject | antipsychotics | - |
dc.subject | treatment | - |
dc.subject | guideline | - |
dc.subject | recommendation | - |
dc.title | A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia | - |
dc.type | Article | - |
dc.identifier.email | Hui, CLM: christyh@hku.hk | - |
dc.identifier.email | Lam, BST: berthal@hku.hk | - |
dc.identifier.email | Lee, EHM: edwinlhm@hku.hk | - |
dc.identifier.email | Chan, SKW: kwsherry@hku.hk | - |
dc.identifier.email | Chang, WC: changwc@hku.hk | - |
dc.identifier.email | Suen, YN: suenyn@hku.hk | - |
dc.identifier.email | Chen, EYH: eyhchen@hku.hk | - |
dc.identifier.authority | Hui, CLM=rp01993 | - |
dc.identifier.authority | Lee, EHM=rp01575 | - |
dc.identifier.authority | Chan, SKW=rp00539 | - |
dc.identifier.authority | Chang, WC=rp01465 | - |
dc.identifier.authority | Suen, YN=rp02481 | - |
dc.identifier.authority | Chen, EYH=rp00392 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1080/09540261.2019.1613965 | - |
dc.identifier.pmid | 31225767 | - |
dc.identifier.scopus | eid_2-s2.0-85073965499 | - |
dc.identifier.hkuros | 310155 | - |
dc.identifier.volume | 31 | - |
dc.identifier.issue | 5-6 | - |
dc.identifier.spage | 441 | - |
dc.identifier.epage | 459 | - |
dc.identifier.isi | WOS:000475121600001 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 0954-0261 | - |